Clinical Trial

Clinical Trials of IBI3035 in Healthy Subjects

Name: Clinical Trials of IBI3035 in Healthy Subjects — clinical trial record (NCT07591519)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This study is a Phase I clinical trial that uses positive glucose clamping technology to evaluate the pharmacokinetic (PK) and pharmacodynamic (PD) bioequivalence of IBI3035 with insulin injection (Awiqli?) after a single administration in healthy male subjects

Protocol Amendment History 1 change

critical Recruitment opened 2026-07-17

Trial Details

NCT Number	NCT07591519
Lead Sponsor	Innovent Biologics (Suzhou) Co. Ltd.
Conditions	Healthy Person
Enrollment	144 participants
Start Date	2026-05-08
Primary Completion	2027-07-30 (estimated)
Study Completion	2027-08-31 (estimated)
Updated on ClinicalTrials.gov	2026-07-16